Skip to main content
Erschienen in: Wiener Medizinische Wochenschrift 11-12/2012

01.06.2012 | main topic

TBE—update on vaccination recommendations for children, adolescents, and adults

verfasst von: Tomas Jelinek, MD, PhD, DTM&H

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 11-12/2012

Einloggen, um Zugang zu erhalten

Summary

Vaccines against tick-born encephalitis (TBE) are well established in Europe. Two highly immunogenic and safe products are available, FSME-IMMUN and Encepur. Extensive research has been published regarding all aspects of standard and rapid immunization schedules, covaccination, and vaccine interchangeability. Long-term effectiveness and resulting recommendations for booster intervals remain topics of discussion. Vaccination is recommended in Switzerland and in Germany for adults and children living in, or travelling to, endemic areas. Austria has recommended universal vaccination since 1981. It is noteworthy that Austria is the only country in Europe that has experienced a decrease in caseload during the last 20 years. This is almost certainly due to the very high vaccine coverage rate of 86 %.
Literatur
1.
Zurück zum Zitat WHO. Vaccines against tick-borne encephalitis: WHO position paper. Weekly Epidemiological Record. 2011;86:241–56. WHO. Vaccines against tick-borne encephalitis: WHO position paper. Weekly Epidemiological Record. 2011;86:241–56.
2.
Zurück zum Zitat Holzmann H, Kundi M, Stiasny K, Clement J, McKenna P, Kunz C, et al. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol. 1996;48:102–7.PubMedCrossRef Holzmann H, Kundi M, Stiasny K, Clement J, McKenna P, Kunz C, et al. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol. 1996;48:102–7.PubMedCrossRef
3.
Zurück zum Zitat Demicheli V, Debalini MG, Rivetti A. Vaccines for preventing tick-borne encephalitis. Cochrane Database Syst Rev. 2009:CD000977. Demicheli V, Debalini MG, Rivetti A. Vaccines for preventing tick-borne encephalitis. Cochrane Database Syst Rev. 2009:CD000977.
4.
Zurück zum Zitat Schoendorf I, Ternak G, Oroszlan G, Nicolay U, Banzhoff A, Zent O. Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21). Hum Vaccin. 2007;3:42–7.PubMedCrossRef Schoendorf I, Ternak G, Oroszlan G, Nicolay U, Banzhoff A, Zent O. Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21). Hum Vaccin. 2007;3:42–7.PubMedCrossRef
5.
Zurück zum Zitat Paulke-Korinek M, Rendi-Wagner P, Kundi M, Laaber B, Wiedermann U, Kollaritsch H. Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection. Vaccine. 2009;27:7027–30.PubMedCrossRef Paulke-Korinek M, Rendi-Wagner P, Kundi M, Laaber B, Wiedermann U, Kollaritsch H. Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection. Vaccine. 2009;27:7027–30.PubMedCrossRef
6.
Zurück zum Zitat Hainz U, Jenewein B, Asch E, Pfeiffer KP, Berger P, Grubeck-Loebenstein B. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine. 2005;23:3232–5.PubMedCrossRef Hainz U, Jenewein B, Asch E, Pfeiffer KP, Berger P, Grubeck-Loebenstein B. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine. 2005;23:3232–5.PubMedCrossRef
7.
Zurück zum Zitat Weinberger B, Keller M, Fischer KH, Stiasny K, Neuner C, Heinz FX, et al. Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50–90 years. Vaccine. 2010;28:3511–5.PubMedCrossRef Weinberger B, Keller M, Fischer KH, Stiasny K, Neuner C, Heinz FX, et al. Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50–90 years. Vaccine. 2010;28:3511–5.PubMedCrossRef
8.
Zurück zum Zitat Stiasny K, Holzmann H, Heinz FX. Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs. Vaccine. 2009;27:7021–6.PubMedCrossRef Stiasny K, Holzmann H, Heinz FX. Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs. Vaccine. 2009;27:7021–6.PubMedCrossRef
9.
Zurück zum Zitat Andersson CR, Vene S, Insulander M, Lindquist L, Lundkvist A, Gunther G. Vaccine failures after active immunization against tick-borne encephalitis. Vaccine. 2010;28:2827–31.PubMedCrossRef Andersson CR, Vene S, Insulander M, Lindquist L, Lundkvist A, Gunther G. Vaccine failures after active immunization against tick-borne encephalitis. Vaccine. 2010;28:2827–31.PubMedCrossRef
10.
Zurück zum Zitat Heinz FX, Holzmann H, Essl A, Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine. 2007;25:7559–67.PubMedCrossRef Heinz FX, Holzmann H, Essl A, Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine. 2007;25:7559–67.PubMedCrossRef
11.
Zurück zum Zitat Rendi-Wagner P, Zent O, Jilg W, Plentz A, Beran J, Kollaritsch H. Persistence of antibodies after vaccination against tick-borne encephalitis. Int J Med Microbiol. 2006;296(Suppl 40):202–7.PubMedCrossRef Rendi-Wagner P, Zent O, Jilg W, Plentz A, Beran J, Kollaritsch H. Persistence of antibodies after vaccination against tick-borne encephalitis. Int J Med Microbiol. 2006;296(Suppl 40):202–7.PubMedCrossRef
12.
Zurück zum Zitat Rendi-Wagner P, Paulke-Korinek M, Kundi M, Wiedermann U, Laaber B, Kollaritsch H. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up. Vaccine. 2007;25:5097–5101.PubMedCrossRef Rendi-Wagner P, Paulke-Korinek M, Kundi M, Wiedermann U, Laaber B, Kollaritsch H. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up. Vaccine. 2007;25:5097–5101.PubMedCrossRef
13.
Zurück zum Zitat Plentz A, Jilg W, Schwarz TF, Kuhr HB, Zent O. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur® Adults. Vaccine. 2009;27:853–6.PubMedCrossRef Plentz A, Jilg W, Schwarz TF, Kuhr HB, Zent O. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur® Adults. Vaccine. 2009;27:853–6.PubMedCrossRef
14.
Zurück zum Zitat Wittermann C, Schondorf I, Gniel D. Antibody response following administration of two pediatric tick-borne encephalitis vaccines using two different vaccination schedules. Vaccine. 2009;27:1661–6.PubMedCrossRef Wittermann C, Schondorf I, Gniel D. Antibody response following administration of two pediatric tick-borne encephalitis vaccines using two different vaccination schedules. Vaccine. 2009;27:1661–6.PubMedCrossRef
15.
Zurück zum Zitat Petri E, Gniel D, Zent O. Tick-borne encephalitis (TBE) trends in epidemiology and current and future management. Travel Med Infect Dis. 2010;8:233–45.PubMedCrossRef Petri E, Gniel D, Zent O. Tick-borne encephalitis (TBE) trends in epidemiology and current and future management. Travel Med Infect Dis. 2010;8:233–45.PubMedCrossRef
16.
Zurück zum Zitat Anonymous. Risikogebiete in Deutschland. Epid Bull. 2011;17:133–45. Anonymous. Risikogebiete in Deutschland. Epid Bull. 2011;17:133–45.
Metadaten
Titel
TBE—update on vaccination recommendations for children, adolescents, and adults
verfasst von
Tomas Jelinek, MD, PhD, DTM&H
Publikationsdatum
01.06.2012
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 11-12/2012
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-012-0112-1

Weitere Artikel der Ausgabe 11-12/2012

Wiener Medizinische Wochenschrift 11-12/2012 Zur Ausgabe